Please assess the completion status of the following clinical trial:

Trial Title: The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Female and male patients who aged above 19 and below 75~* Patients with 90\~109mmHg average sitting DBP on baseline~* NYHA class 2\~4~* Patients who agreement with written informed consent~Exclusion Criteria:~* above 110mmHg sitting DBP and/or 180mmHg sitting SBP~* Patients who have difference values that above 20mmHg sitting SBP or 10mmHg sitting DBP in both arms on screening~* Patients who have medical history that secondary hypertension or rule out secondary hypertension~* malignant hypertension~* symptomatic postural hypotension~* right heart failure due to pulmonary disease~* etc.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Candemore tablet (Type: EXPERIMENTAL): Candemore tablet: candesartan cilexetil 8mg, 16mg, 32mg/tab, orally, 1 tablet once a day during 16 weeks
- Cozzar tablet (Type: ACTIVE_COMPARATOR): Cozzar tablet: Losartan potassium 50mg, 100mg/cap, orally, 1 capsule once a day during 16 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).